 | • レポートコード：QFJ1-5808 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、体外毒性検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静的ウェルプレートシステム、マルチコンパートメント灌流システム）、用途別市場規模（製薬・バイオテクノロジー企業、学術研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・体外毒性検査の市場動向 ・企業の競争状況、市場シェア ・体外毒性検査の種類別市場規模と予測2016-2027（静的ウェルプレートシステム、マルチコンパートメント灌流システム） ・体外毒性検査の用途別市場規模と予測2016-2027（製薬・バイオテクノロジー企業、学術研究機関、その他） ・体外毒性検査の北米市場規模2016-2027（アメリカ、カナダ） ・体外毒性検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・体外毒性検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・体外毒性検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・体外毒性検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、CELTHER POLSKA Sp z o.o.、Charles River Laboratories International Inc.、Eurofins GSC Lux Sarl、Evotec AG、General Electric Co.、Merck KGaA、Thermo Fisher Scientific Inc.） ・結論 |
In-vitro and in-silico testing methods are being preferred over in-vivo testing methods in the pharmaceutical industry because of the growing need to detect diseases at the molecular level and identify biological functionalities with minimal adverse effects.
The development of advanced technologies, such as 3D cell culture technologies, cellular imaging technologies, and toxicogenomics has further supported the adoption of in-vitro testing methods. These technologies help in replicating in-vivo systems and thereby eliminate the need to experiment on human or animal models.
Market Analysis and Insights: Global In-vitro Toxicity Testing Market
The global In-vitro Toxicity Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-vitro Toxicity Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-vitro Toxicity Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-vitro Toxicity Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-vitro Toxicity Testing market.
Global In-vitro Toxicity Testing Scope and Market Size
In-vitro Toxicity Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Toxicity Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Static Well Plate System
Multi-compartmental Perfused Systems
Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
CELTHER POLSKA Sp z o.o.
Charles River Laboratories International Inc.
Eurofins GSC Lux Sarl
Evotec AG
General Electric Co.
Merck KGaA
Thermo Fisher Scientific Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Static Well Plate System
1.2.3 Multi-compartmental Perfused Systems
1.3 Market by Application
1.3.1 Global In-vitro Toxicity Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Toxicity Testing Market Perspective (2016-2027)
2.2 In-vitro Toxicity Testing Growth Trends by Regions
2.2.1 In-vitro Toxicity Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-vitro Toxicity Testing Historic Market Share by Regions (2016-2021)
2.2.3 In-vitro Toxicity Testing Forecasted Market Size by Regions (2022-2027)
2.3 In-vitro Toxicity Testing Industry Dynamic
2.3.1 In-vitro Toxicity Testing Market Trends
2.3.2 In-vitro Toxicity Testing Market Drivers
2.3.3 In-vitro Toxicity Testing Market Challenges
2.3.4 In-vitro Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Toxicity Testing Players by Revenue
3.1.1 Global Top In-vitro Toxicity Testing Players by Revenue (2016-2021)
3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2016-2021)
3.2 Global In-vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-vitro Toxicity Testing Revenue
3.4 Global In-vitro Toxicity Testing Market Concentration Ratio
3.4.1 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Toxicity Testing Revenue in 2020
3.5 In-vitro Toxicity Testing Key Players Head office and Area Served
3.6 Key Players In-vitro Toxicity Testing Product Solution and Service
3.7 Date of Enter into In-vitro Toxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Toxicity Testing Breakdown Data by Type
4.1 Global In-vitro Toxicity Testing Historic Market Size by Type (2016-2021)
4.2 Global In-vitro Toxicity Testing Forecasted Market Size by Type (2022-2027)
5 In-vitro Toxicity Testing Breakdown Data by Application
5.1 Global In-vitro Toxicity Testing Historic Market Size by Application (2016-2021)
5.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In-vitro Toxicity Testing Market Size (2016-2027)
6.2 North America In-vitro Toxicity Testing Market Size by Type
6.2.1 North America In-vitro Toxicity Testing Market Size by Type (2016-2021)
6.2.2 North America In-vitro Toxicity Testing Market Size by Type (2022-2027)
6.2.3 North America In-vitro Toxicity Testing Market Size by Type (2016-2027)
6.3 North America In-vitro Toxicity Testing Market Size by Application
6.3.1 North America In-vitro Toxicity Testing Market Size by Application (2016-2021)
6.3.2 North America In-vitro Toxicity Testing Market Size by Application (2022-2027)
6.3.3 North America In-vitro Toxicity Testing Market Size by Application (2016-2027)
6.4 North America In-vitro Toxicity Testing Market Size by Country
6.4.1 North America In-vitro Toxicity Testing Market Size by Country (2016-2021)
6.4.2 North America In-vitro Toxicity Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In-vitro Toxicity Testing Market Size (2016-2027)
7.2 Europe In-vitro Toxicity Testing Market Size by Type
7.2.1 Europe In-vitro Toxicity Testing Market Size by Type (2016-2021)
7.2.2 Europe In-vitro Toxicity Testing Market Size by Type (2022-2027)
7.2.3 Europe In-vitro Toxicity Testing Market Size by Type (2016-2027)
7.3 Europe In-vitro Toxicity Testing Market Size by Application
7.3.1 Europe In-vitro Toxicity Testing Market Size by Application (2016-2021)
7.3.2 Europe In-vitro Toxicity Testing Market Size by Application (2022-2027)
7.3.3 Europe In-vitro Toxicity Testing Market Size by Application (2016-2027)
7.4 Europe In-vitro Toxicity Testing Market Size by Country
7.4.1 Europe In-vitro Toxicity Testing Market Size by Country (2016-2021)
7.4.2 Europe In-vitro Toxicity Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Toxicity Testing Market Size (2016-2027)
8.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type
8.2.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application
8.3.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific In-vitro Toxicity Testing Market Size by Region
8.4.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-vitro Toxicity Testing Market Size (2016-2027)
9.2 Latin America In-vitro Toxicity Testing Market Size by Type
9.2.1 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2021)
9.2.2 Latin America In-vitro Toxicity Testing Market Size by Type (2022-2027)
9.2.3 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2027)
9.3 Latin America In-vitro Toxicity Testing Market Size by Application
9.3.1 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2021)
9.3.2 Latin America In-vitro Toxicity Testing Market Size by Application (2022-2027)
9.3.3 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2027)
9.4 Latin America In-vitro Toxicity Testing Market Size by Country
9.4.1 Latin America In-vitro Toxicity Testing Market Size by Country (2016-2021)
9.4.2 Latin America In-vitro Toxicity Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Toxicity Testing Market Size (2016-2027)
10.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type
10.2.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application
10.3.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa In-vitro Toxicity Testing Market Size by Country
10.4.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In-vitro Toxicity Testing Introduction
11.1.4 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies Inc.
11.2.1 Agilent Technologies Inc. Company Details
11.2.2 Agilent Technologies Inc. Business Overview
11.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Introduction
11.2.4 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.2.5 Agilent Technologies Inc. Recent Development
11.3 Bio-Rad Laboratories Inc.
11.3.1 Bio-Rad Laboratories Inc. Company Details
11.3.2 Bio-Rad Laboratories Inc. Business Overview
11.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.3.5 Bio-Rad Laboratories Inc. Recent Development
11.4 CELTHER POLSKA Sp z o.o.
11.4.1 CELTHER POLSKA Sp z o.o. Company Details
11.4.2 CELTHER POLSKA Sp z o.o. Business Overview
11.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Introduction
11.4.4 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.4.5 CELTHER POLSKA Sp z o.o. Recent Development
11.5 Charles River Laboratories International Inc.
11.5.1 Charles River Laboratories International Inc. Company Details
11.5.2 Charles River Laboratories International Inc. Business Overview
11.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Introduction
11.5.4 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.5.5 Charles River Laboratories International Inc. Recent Development
11.6 Eurofins GSC Lux Sarl
11.6.1 Eurofins GSC Lux Sarl Company Details
11.6.2 Eurofins GSC Lux Sarl Business Overview
11.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Introduction
11.6.4 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.6.5 Eurofins GSC Lux Sarl Recent Development
11.7 Evotec AG
11.7.1 Evotec AG Company Details
11.7.2 Evotec AG Business Overview
11.7.3 Evotec AG In-vitro Toxicity Testing Introduction
11.7.4 Evotec AG Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.7.5 Evotec AG Recent Development
11.8 General Electric Co.
11.8.1 General Electric Co. Company Details
11.8.2 General Electric Co. Business Overview
11.8.3 General Electric Co. In-vitro Toxicity Testing Introduction
11.8.4 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.8.5 General Electric Co. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA In-vitro Toxicity Testing Introduction
11.9.4 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.9.5 Merck KGaA Recent Development
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Details
11.10.2 Thermo Fisher Scientific Inc. Business Overview
11.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Introduction
11.10.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021)
11.10.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global In-vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Static Well Plate System
Table 3. Key Players of Multi-compartmental Perfused Systems
Table 4. Global In-vitro Toxicity Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global In-vitro Toxicity Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global In-vitro Toxicity Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global In-vitro Toxicity Testing Market Share by Regions (2016-2021)
Table 8. Global In-vitro Toxicity Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global In-vitro Toxicity Testing Market Share by Regions (2022-2027)
Table 10. In-vitro Toxicity Testing Market Trends
Table 11. In-vitro Toxicity Testing Market Drivers
Table 12. In-vitro Toxicity Testing Market Challenges
Table 13. In-vitro Toxicity Testing Market Restraints
Table 14. Global In-vitro Toxicity Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global In-vitro Toxicity Testing Market Share by Players (2016-2021)
Table 16. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2020)
Table 17. Ranking of Global Top In-vitro Toxicity Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by In-vitro Toxicity Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-vitro Toxicity Testing Product Solution and Service
Table 21. Date of Enter into In-vitro Toxicity Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global In-vitro Toxicity Testing Revenue Market Share by Type (2016-2021)
Table 25. Global In-vitro Toxicity Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global In-vitro Toxicity Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global In-vitro Toxicity Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global In-vitro Toxicity Testing Revenue Market Share by Application (2016-2021)
Table 29. Global In-vitro Toxicity Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global In-vitro Toxicity Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories In-vitro Toxicity Testing Product
Table 64. Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Agilent Technologies Inc. Company Details
Table 67. Agilent Technologies Inc. Business Overview
Table 68. Agilent Technologies Inc. In-vitro Toxicity Testing Product
Table 69. Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 70. Agilent Technologies Inc. Recent Development
Table 71. Bio-Rad Laboratories Inc. Company Details
Table 72. Bio-Rad Laboratories Inc. Business Overview
Table 73. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product
Table 74. Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories Inc. Recent Development
Table 76. CELTHER POLSKA Sp z o.o. Company Details
Table 77. CELTHER POLSKA Sp z o.o. Business Overview
Table 78. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product
Table 79. CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 80. CELTHER POLSKA Sp z o.o. Recent Development
Table 81. Charles River Laboratories International Inc. Company Details
Table 82. Charles River Laboratories International Inc. Business Overview
Table 83. Charles River Laboratories International Inc. In-vitro Toxicity Testing Product
Table 84. Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 85. Charles River Laboratories International Inc. Recent Development
Table 86. Eurofins GSC Lux Sarl Company Details
Table 87. Eurofins GSC Lux Sarl Business Overview
Table 88. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product
Table 89. Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 90. Eurofins GSC Lux Sarl Recent Development
Table 91. Evotec AG Company Details
Table 92. Evotec AG Business Overview
Table 93. Evotec AG In-vitro Toxicity Testing Product
Table 94. Evotec AG Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 95. Evotec AG Recent Development
Table 96. General Electric Co. Company Details
Table 97. General Electric Co. Business Overview
Table 98. General Electric Co. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 99. General Electric Co. Recent Development
Table 100. Merck KGaA Company Details
Table 101. Merck KGaA Business Overview
Table 102. Merck KGaA In-vitro Toxicity Testing Product
Table 103. Merck KGaA Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 104. Merck KGaA Recent Development
Table 105. Thermo Fisher Scientific Inc. Company Details
Table 106. Thermo Fisher Scientific Inc. Business Overview
Table 107. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product
Table 108. Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million)
Table 109. Thermo Fisher Scientific Inc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-vitro Toxicity Testing Market Share by Type: 2020 VS 2027
Figure 2. Static Well Plate System Features
Figure 3. Multi-compartmental Perfused Systems Features
Figure 4. Global In-vitro Toxicity Testing Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical and Biotechnology Companies Case Studies
Figure 6. Academic and Research Institutions Case Studies
Figure 7. Others Case Studies
Figure 8. In-vitro Toxicity Testing Report Years Considered
Figure 9. Global In-vitro Toxicity Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global In-vitro Toxicity Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global In-vitro Toxicity Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global In-vitro Toxicity Testing Market Share by Regions (2022-2027)
Figure 13. Global In-vitro Toxicity Testing Market Share by Players in 2020
Figure 14. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by In-vitro Toxicity Testing Revenue in 2020
Figure 16. Global In-vitro Toxicity Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global In-vitro Toxicity Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America In-vitro Toxicity Testing Market Share by Type (2016-2027)
Figure 20. North America In-vitro Toxicity Testing Market Share by Application (2016-2027)
Figure 21. North America In-vitro Toxicity Testing Market Share by Country (2016-2027)
Figure 22. United States In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe In-vitro Toxicity Testing Market Share by Type (2016-2027)
Figure 26. Europe In-vitro Toxicity Testing Market Share by Application (2016-2027)
Figure 27. Europe In-vitro Toxicity Testing Market Share by Country (2016-2027)
Figure 28. Germany In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific In-vitro Toxicity Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific In-vitro Toxicity Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific In-vitro Toxicity Testing Market Share by Region (2016-2027)
Figure 38. China In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America In-vitro Toxicity Testing Market Share by Type (2016-2027)
Figure 46. Latin America In-vitro Toxicity Testing Market Share by Application (2016-2027)
Figure 47. Latin America In-vitro Toxicity Testing Market Share by Country (2016-2027)
Figure 48. Mexico In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa In-vitro Toxicity Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa In-vitro Toxicity Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa In-vitro Toxicity Testing Market Share by Country (2016-2027)
Figure 54. Turkey In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 58. Agilent Technologies Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 59. Bio-Rad Laboratories Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 60. CELTHER POLSKA Sp z o.o. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 61. Charles River Laboratories International Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 62. Eurofins GSC Lux Sarl Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 63. Evotec AG Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 64. General Electric Co. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 65. Merck KGaA Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 66. Thermo Fisher Scientific Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の放射線毒性治療薬市場規模・現状・予測（2021年-2027年） Treatment of acute radiation syndrome is generally supportive care. This may include blood transfusions, antibiotics, colony-stimulating factors, or stem cell transplant. If radioactive material remains on the skin or in the stomach it should be removed. Market Analysis and Insights: Global Radiatio…- 世界の放射線毒性治療市場規模・現状・予測（2021年-2027年） Treatment of acute radiation syndrome is generally supportive care. This may include blood transfusions, antibiotics, colony-stimulating factors, or stem cell transplant. If radioactive material remains on the skin or in the stomach it should be removed. Market Analysis and Insights: Global Radiatio…
- 世界の体外診断（IVD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In Vitro Diagnostics(IVD) Market The global In Vitro Diagnostics(IVD) market size is projected to reach US$ 120900 million by 2027, from US$ 76910 million in 2020, at a CAGR of 6.6% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界の感染症用体外診断薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Infectious Diseases In Vitro Diagnostics Market The global Infectious Diseases In Vitro Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
- 世界の体外＆体内微小電極アレイ市場規模・現状・予測（2021年-2027年） Microelectrode arrays are also known as multi-electrode arrays. Microelectrode arrays are devices, which have many (tens to thousands) shanks or plates also known as micro-electrodes. Neural signals are delivered by connecting neurons to electronic circuitry. Non-implantable microelectrode arrays ar…